PMC:7536913 / 10798-11015 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7536913","sourcedb":"PMC","sourceid":"7536913","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7536913","text":"The practice of deferring or eliminating certain preclinical studies while there is a degree of uncertainty in the experimental candidate for specific life‐threatening illnesses with no effective treatment is not new.","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T55","span":{"begin":84,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T55","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T71","span":{"begin":0,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T71","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#96ec93","default":true},{"id":"LitCovid-sentences","color":"#ec93b0"}]}]}}